Taiwan Hopax Chemicals Manufacturing Co. Ltd. AI Stock Analysis
Taiwan Hopax Chemicals Manufacturing Co. Ltd. (6509) AI Stock Analysis
Taiwan Hopax Chemicals Manufacturing Co. Ltd.
(TPEx:6509)
Strong financial performance from margin expansion and lower leverage is the primary driver, supported by reasonable valuation. Short-term technical weakness from moving averages and MACD tempers the score but oversold conditions limit further downside risk.
Taiwan Hopax Chemicals Manufacturing Co. Ltd. (6509) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 9.09B
- Dividend Yield
- 3.23%
- Average Volume (3M)
- 887.52K
- Price to Earnings (P/E)
- 13.0
- Beta (1Y)
- 0.73
- Revenue Growth
- 2.00%
- EPS Growth
- 57.23%
- Country
- TW
- Employees
- 891
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Taiwan Hopax Chemicals Manufacturing Co. Ltd. Business Overview & Revenue Model
Company Description
Taiwan Hopax Chemicals Manufacturing Co., Ltd. (Hopax) operates as a global manufacturer and supplier, specializing in a diverse array of chemical solutions. The company's core business encompasses the production and sale of specialty chemicals, fine...
Taiwan Hopax Chemicals Manufacturing Co. Ltd. Financial Statement Overview
Summary
Profitability strengthened with gross margins at 32.3% and net margins at 11.6%, balance sheet improved via deleveraging to debt-to-equity of 0.30, backed by solid operating cash flow of 1.22 billion.
Income Statement
76PositiveBalance Sheet
84Very PositiveCash Flow
71Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.00B | 4.88B | 4.75B | 4.52B | 5.46B | 4.73B |
| Gross Profit | 1.75B | 1.58B | 1.45B | 1.26B | 1.51B | 1.32B |
| EBITDA | 1.32B | 1.11B | 995.96M | 869.08M | 1.08B | 865.80M |
| Net Income | 710.54M | 567.43M | 489.91M | 429.99M | 599.35M | 428.81M |
Balance Sheet | ||||||
| Total Assets | 8.26B | 7.87B | 7.33B | 6.08B | 6.68B | 6.25B |
| Cash, Cash Equivalents and Short-Term Investments | 1.87B | 1.74B | 1.65B | 703.65M | 637.80M | 521.43M |
| Total Debt | 1.27B | 1.56B | 1.40B | 1.45B | 2.07B | 2.04B |
| Total Liabilities | 2.69B | 2.63B | 2.28B | 2.35B | 3.11B | 3.11B |
| Stockholders Equity | 5.57B | 5.25B | 5.04B | 3.73B | 3.56B | 3.14B |
Cash Flow | ||||||
| Free Cash Flow | 559.58M | 814.73M | 266.97M | 881.22M | 342.01M | 105.67M |
| Operating Cash Flow | 960.24M | 1.22B | 546.06M | 1.15B | 679.77M | 355.34M |
| Investing Cash Flow | -371.75M | -484.99M | -284.74M | -254.36M | -299.55M | -331.05M |
| Financing Cash Flow | -476.56M | -730.41M | 657.94M | -783.97M | -232.50M | -115.36M |
Taiwan Hopax Chemicals Manufacturing Co. Ltd. Peers Comparison
Overall Rating
TW:650972Outperform
TW:370849Neutral
TW:473946Neutral
TW:430644Neutral
TW:498941Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 72Outperform | TWD 9.02B | 12.96 | ― | 3.23% | 2.00% | 57.23% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 49Neutral | TWD 8.37B | 2.73 | ― | 6.94% | -79.42% | 2756.52% | |
| 46Neutral | TWD 8.41B | 13.42 | ― | 1.41% | 98.05% | 725.72% | |
| 44Neutral | TWD 9.28B | 15.44 | ― | 4.96% | 4.17% | 151.80% | |
| 41Neutral | TWD 10.18B | -37.53 | ― | ― | 63.30% | 87.48% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:6509 | Taiwan Hopax Chemicals Manufacturing Co. Ltd. | 43.20 | 10.94 | 33.93% | |
| TW:3708 | Swancor Holding Co., Ltd. | 93.60 | -27.17 | -22.50% | |
| TW:4306 | Yem Chio Co., Ltd. | 14.10 | 1.26 | 9.80% | |
| TW:4739 | Coremax Corporation | 71.00 | -0.53 | -0.74% | |
| TW:4989 | LCY Technology Corp. | 60.90 | 13.39 | 28.18% | |
| TW:7763 | Johnson Fine Chemical Co Ltd | 141.50 | 66.66 | 89.07% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
